Prescription of anti-osteoporosis drugs during 2004-2007-a nationwide register study in Norway.
about
Long-term safety concerns of antiresorptive therapy.Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: Variation by age, sex, geographic location and ethnicityForearm fractures in Central Norway, 1999-2012: incidence, time trends, and seasonal variation.Use of anti-osteoporotic drugs in central Norway after a forearm fracture.Hip fracture incidence is decreasing in the high incidence area of Oslo, Norway.Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway.Hip fracture and other predictors of anti-osteoporosis drug use in Norway.Prescription of teriparatide in the UK--a nationwide register study from 2004 to 2008.Is drug utilization in Greece sex dependent? A population-based study.Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures.Changes in first hip fracture rates in British Columbia Canada, 1990-2004.Variation in Antiosteoporotic Drug Prescribing and Spending Across Spain. A Population-Based Ecological Cross-Sectional Study.Variations in osteoporosis medication utilization. A population-based ecological cross-sectional study in the region of Valencia, Spain.Post-hip fracture use of prescribed calcium plus vitamin D or vitamin D supplements and antiosteoporotic drugs is associated with lower mortality: A nationwide study in Finland
P2860
Q35570961-3293D903-2640-4EEC-9B8B-2B443905B82BQ37443313-8D399F1C-19DE-4BFF-AAF4-E6A9FD84203BQ40093395-83D0B715-9C87-42CC-9453-8F4AE5797172Q40580195-DE07180F-0D3A-47E5-B102-D1EDA20847F1Q43728726-4734AC5A-2E28-4CD5-A63A-B02C0DEFAC31Q44669281-0950B7E6-2538-4DE7-85F1-6380BEA74C5DQ44820522-E841672D-B00D-4C0A-BF51-A5F2922C3B20Q45347455-26C68BD1-74FF-4CCE-9522-ED3E8165DC29Q47423590-D58B7E88-5958-4F78-A0EA-A43F3FED7D6AQ47727040-7458993A-671F-4C96-A74F-A59AD498788DQ51058027-4E175ABA-DF97-469C-8E5E-598BF948F42DQ54959222-FD1D8FFC-FCBB-4167-9730-914D4B38B308Q55486198-3CEF5564-62A9-413F-A036-3D3A6473C6BBQ57543430-7C9FF2A3-53B5-41E2-A37C-B43D90EAAC15
P2860
Prescription of anti-osteoporosis drugs during 2004-2007-a nationwide register study in Norway.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Prescription of anti-osteoporo ...... wide register study in Norway.
@en
Prescription of anti-osteoporo ...... wide register study in Norway.
@nl
type
label
Prescription of anti-osteoporo ...... wide register study in Norway.
@en
Prescription of anti-osteoporo ...... wide register study in Norway.
@nl
prefLabel
Prescription of anti-osteoporo ...... wide register study in Norway.
@en
Prescription of anti-osteoporo ...... wide register study in Norway.
@nl
P2093
P1476
Prescription of anti-osteoporo ...... wide register study in Norway.
@en
P2093
Anne Johanne Sogaard
Gia Man Doung
Haakon E Meyer
Helene M Devold
Jan A Falch
P2888
P304
P356
10.1007/S00228-009-0746-0
P50
P577
2009-11-07T00:00:00Z